19 studies found for:    "Endometrial stromal sarcoma"
Show Display Options
Rank Status Study
1 Completed AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
Conditions: Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Malignant Fibrous Histiocytoma;   Adult Rhabdomyosarcoma;   Dermatofibrosarcoma Protuberans;   Endometrial Stromal Sarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Uterine Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma;   Uterine Leiomyosarcoma
Intervention: Drug: saracatinib
2 Suspended Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Alveolar Soft-part Sarcoma;   Adult Angiosarcoma;   Adult Epithelioid Sarcoma;   Adult Extraskeletal Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Liposarcoma;   Adult Neurofibrosarcoma;   Chondrosarcoma;   Endometrial Stromal Sarcoma;   Mast Cell Sarcoma;   Metastatic Adult Malignant Fibrous Histiocytoma of Bone;   Ovarian Carcinosarcoma;   Ovarian Sarcoma;   Recurrent Adult Malignant Fibrous Histiocytoma of Bone;   Recurrent Adult Soft Tissue Sarcoma;   Small Intestine Leiomyosarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: alisertib;   Other: laboratory biomarker analysis
3 Active, not recruiting Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: Endometrial Adenoacanthoma;   Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Endometrial Stromal Sarcoma;   Recurrent Endometrial Carcinoma
Intervention: Biological: trebananib
4 Completed Mifepristone for Patients With Endometrial Cancer and LGESS
Condition: Endometrial Cancer
Intervention: Drug: Mifepristone
5 Completed Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: conventional surgery
6 Unknown  Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
7 Completed Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: perifosine
8 Completed Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Desmoid Tumor;   Endometrial Cancer;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: sunitinib malate
9 Terminated Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Condition: Cancer
Interventions: Drug: cyproheptadine hydrochloride;   Other: placebo
10 Completed Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Conditions: Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Sarcoma
Interventions: Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride
11 Completed Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
12 Completed Chemotherapy in Treating Patients With Sarcoma of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: pegylated liposomal doxorubicin hydrochloride
13 Completed Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Radiation: radiation therapy
14 Completed Thalidomide in Treating Patients With Gynecologic Sarcomas
Conditions: Endometrial Cancer;   Sarcoma
Intervention: Drug: thalidomide
15 Completed Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Brain and Central Nervous System Tumors;   Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: trabectedin
16 Completed STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Gastrointestinal Stromal Tumor;   Ovarian Cancer;   Sarcoma;   Small Intestine Cancer
Intervention: Drug: imatinib mesylate
17 Unknown  Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Ovarian Cancer;   Sarcoma
Intervention: Drug: temozolomide
18 Completed BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Conditions: Breast Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Melanoma (Skin);   Ovarian Cancer;   Sarcoma
Interventions: Drug: BI 2536;   Other: high performance liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study
19 Completed Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate

Indicates status has not been verified in more than two years